Bristol-Myers Squibb's Opdivo has been recommended as a treatment for around 3,000 people with rare forms of gastro-oesophageal cancer via the NHS in England and Wales. In final guidance ...

A woman from Scotland has become the first patient in Europe to receive a cancer jab for gastro-oesophageal cancer. Jennifer ...